Article Details
Retrieved on: 2025-02-05 21:04:44
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Jabil's acquisition of Pharmaceutics International, enhancing capabilities in drug delivery manufacturing, and Eli Lilly expanding its manufacturing for diabetes therapies, linking the key concept of diabetes with pharmaceutical industry developments.
Article found on: www.pharmtech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here